Page 41 - Ryan Noach News Today

Analysis by Discovery and SA Medical Research Council finds vaccine reduces need for admission to hospital with severe Covid by 70%

A preliminary study shows the Omicron variant is 'highly transmissible' and may better evade vaccines.

Pfizer announced Tuesday that clinical trials conducted with its Covid pill, a new antiviral drug designed to withstand mutations of Omicron

The omicron variant appears to cause less severe disease than previous strains, South African data suggests. But the Pfizer vaccine seems to offer less defense against infection.

A study in South Africa, where the Omicron variant was first found, appears to show the new strain of COVID-19 is more transmissible, but less deadly.

A large South African analysis found Pfizer’s COVID-19 vaccine offered just 33% protection against infection by the omicron variant, but 70% protection against hospitalization.

A preliminary study shows the Omicron variant is 'highly transmissible' and may better evade vaccines.

A study in South Africa, where the Omicron variant was first found, appears to show the new strain of COVID-19 is more transmissible, but less deadly.

The omicron variant is offering more hints about what it may have in store as it spreads around the globe: A highly transmissible virus that may cause less severe disease, and one that can be slowed — but not stopped — by todays vaccines.

A preliminary study shows the Omicron variant is 'highly transmissible' and may better evade vaccines.